logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
K

Katherine B. Peters

Duke University

46H-index
445Paper Count
9.2KCitation Count
Published Papers 135
Publication Date
logo
Vorasidenib-Induced Acute Liver Injury
errDigestive Diseases and Sciences
IF2.5
err2026-09-11
err0
errOAAI
errEmily A. Lau; David R. Braxton; Didier Autran; Fengming Chen; Aurelie M. Haffner; Jethro Hu; Katherine B. Peters; Tse-Ling Fong
errShare
errSave
NOTQ-04 NEUROCOGNITIVE OUTCOMES IN PATIENTS WITH BRAIN METASTASES: A SYSTEMATIC REVIEW OF PAST FINDINGS AND FUTURE DIRECTIONS
errNeuro-Oncology Advances
IF4.1
err2026-08-07
err0
errOAAI
errTarek Bou Dargham; Sebastian F Winter; Kristen Batich; Karin Gehring; Michael W Parsons; Jorg Dietrich; Trey Mullikin; Zachary J Reitman; Scott R Floyd; John P Kirkpatrick; Paul W Sperduto; Jona Hattangadi-Gluth; Helen A Shih; Paul D Brown; Minesh Mehta; Erik P Sulman; Katherine B Peters; Eugene J Vaios
errShare
errSave
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma
errScience Translational Medicine
IF14.6
err2026-08-05
err0
PREAI
errDiana D. Shi; Ester Calvo Fernández; Vinesh T. Puliyappadamba; Tyler A. Lanman; Yi Xiao; Zebin Wen; Maria Minor; Diego Prost; Aleksandra B. Lasica; Feng Cai; Ethan Neumann; Sriram Gudipelly; Louise M. Clark; Quang-De Nguyen; Salvador Peña; Janaka Wansapura; Pranita Kaphle; Tracey Shipman; Michael M. Levitt; Mathew D. Lin; Alexander C.-Y. Tsai; Joyce H. Lee; Daniel P. Cahill; Rifaquat Rahman; Daphne A. Haas-Kogan; Timothy E. Richardson; Itay Tirosh; Payal Jain; Adriana E. Tron; Vihang Nakhate; Gilbert Youssef; Caroline Dehais; Julian Jacob; David A. Reardon; Julie J. Miller; Kalil G. Abdullah; Patrick Y. Wen; Ralph J. DeBerardinis; Lin Xu; Mehdi Touat; Katherine B. Peters; L. Nicolas Gonzalez Castro; William G. Kaelin; Mario L. Suvà; Samuel K. McBrayer
errShare
errSave
Statin use is associated with reduced stroke risk after cranial radiation in glioma patients with hyperlipidemia
errJournal of Neuro-Oncology
IF3.1
err2026-04-22
err0
PREAI
errDylan Ryan; Katherine B. Peters; Soma Sengupta; Wuwei Feng; Stacie Demel DO; Nishant P. Shah; Nada El Husseini
errShare
errSave
Neurocognitive outcomes in patients with brain metastases: a systematic review
errThe Lancet Oncology
IF0
err2025-11-24
err0
PREAI
errTarek Bou Dargham; Sebastian F Winter; Kristen Batich; Karin Gehring; Michael W Parsons; Jorg Dietrich; Trey Mullikin; Zachary J Reitman; Scott R Floyd; John P Kirkpatrick; Paul W Sperduto; Jona Hattangadi-Gluth; Helen A Shih; Paul D Brown; Minesh Mehta; Erik P Sulman; Katherine B Peters; Eugene J Vaios
errShare
errSave
CTNI-53. PATIENTS WITH ISOCITRATE DEHYDROGENASE-MUTANT GLIOMA TREATED WITH VORASIDENIB: UPDATED DATA FROM THE VORASIDENIB EXPANDED ACCESS PROGRAM
errNeuro-Oncology
IF13.4
err2025-11-11
err0
errOAAI
errTimothy F Cloughesy; Katherine B Peters; Howard Colman; Jennie W Taylor; Ingo K Mellinghoff; Helen A Shih; Christelle Chacar; Jonathan Dewey; Patrick Y Wen
errShare
errSave
INNV-41. Real-World utilization of vorasidenib in patients with IDH-mutant glioma: early insights on patient characteristics, disease history, and prior treatment patterns
errNeuro-Oncology
IF13.4
err2025-11-11
err0
errOAAI
errKatherine B Peters; Mallika P Patel; Tarun Bhagnani; Christelle Chacar; Eros Papademetriou; Ravi Potluri
errShare
errSave
New and Emerging Therapies for Patients with Low-Grade Glioma
errCNS Drugs
IF7.4
err2025-11-07
err0
PREAI
errKatherine B. Peters
errShare
errSave
Clinical trial of feasibility for mindfulness intervention for patients with newly diagnosed high grade glioma
errJournal of Neuro-Oncology
IF3.1
err2025-11-05
err0
PREAI
errKavya Ramamurthy; Dina M. Randazzo; Nicole Cort; James E. Herndon; Evan Buckley; Mary Lou Affronti; Jung-Young Kim; Mallika P. Patel; Justin T. Low; Margaret O. Johnson; Mustafa Khasraw; Annick Desjardins; David M. Ashley; Henry S. Friedman; Katherine B. Peters
errShare
errSave
INVESTIGATION OF THE COMBINATION OF D2C7-IT WITH AN FC-ENGINEERED ANTI-HUMANCD40 MONOCLONAL ANTIBODY (2141-V11) WHEN ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOLLOWED BY CERVICAL PERILYMPHATIC INJECTIONS (CPLIS) OF 2141-V11 COMPARED TO D2C7-IT CED MONOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM)
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errDesjardins, Annick; Chandramohan, Vidya; Herndon II, James E.; Bradbury, Claire; Shoaf, Madison; Peters, Katherine B.; Johnson, Margaret O.; Batich, Kristen; Low, Justin; Khasraw, Mustafa; Friedman, Allan H.; Friedman, Henry S.; Ashley, David M.; Grant, Gerald; Osorio, Juan; Ravetch, Jeffrey; Bigner, Darell D.
errShare
errSave
Volumetric (3D) compared with traditional bidirectional (2D) assessment in patients with Grade 2, isocitrate dehydrogenase 1/2 mutant (mIDH1/2) glioma receiving vorasidenib or placebo in the Phase 3 INDIGO trial
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errEllingson, Benjamin M.; Mellinghoff, Ingo; Van Den Bent, Martin J.; Blumenthal, Deborah T.; Touat, Mehdi; Peters, Katherine B.; Clarke, Jennifer L.; Mendez, Joe; Yust-Katz, Shlomit; Welsh, Liam; Mason, Warren P.; Ducray, Francois; Umemura, Yoshie; Nabors, Burt; Holdhoff, Matthias; Hottinger, Andreas F.; Arakawa, Yoshiki; Sepulveda, Juan M.; Wick, Wolfgang; Soffietti, Riccardo; Perry, James; Giglio, Pierre; De La Fuente, Macarena, I; Maher, Elizabeth; Zhao, Dan; Pandya, Shuchi S.; Steelman, Lori; Hassan, Islam; Wen, Patrick Y.; Cloughesy, Timothy F.
errShare
errSave
Aquaporin-4 loss in astrocytes drives glioblastoma-associated cerebral edema and alters the tumor immune microenvironment
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errJoshi, Tanvi; Flick, Matthew J.; Garvin, Kaisha; Vallcorba, Montserrat Puigdelloses; Dedhia, Mehek; Chen, Zhihong; Peters, Katherine B.; Ramos, Susana Isabel; Tsankova, Nadejda; Tran, Nhan L.; Hu, Leland S.; Smith, Alex J.; Heiland, Dieter Henrik; Hambardzumyan, Dolores
errShare
errSave
Real-world observation rates and treatment patterns in IDH-mutated glioma: implications for targeted therapy use
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errOstrom, Quinn; Bhagnani, Tarun; Benedetti, Julia; Elkholi, Rana; Peters, Katherine B.
errShare
errSave
A phase 2 double-blind, randomized, prospective, placebo-controlled study of NanO2TM combined with radiation and temozolomide in patients with newly diagnosed glioblastoma: RESTORE
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errBadruddoja, Michael; Placencia, Crystal; Goldlust, Samuel; Peters, Katherine; Stea, Baldassarre; Newton, Herbert; Cohen, Adam; Blondin, Nicholas; Aiken, Robert; Goldin, Caroline; Kong, Xiao-Tang; Tsung, Andrew; Wagle, Naveed; Mahadevan, Daruka; Huang, Claire; Johnson, Jeremy; Unger, Evan
errShare
errSave
Evaluating Response to Mutant IDH Inhibition in Lower Grade Gliomas Using Artificial Intelligence-Based Brain Tumor Volumetrics
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errZhang, Jikai; Minor, Maria; Elkholi, Rana; Dewey, Jonathan; Peters, Katherine B.; Calabrese, Evan
errShare
errSave
ASSESSMENT OF AGE IN THE CLINICAL RISK STRATIFICATION OF PATIENTS WITH IDH-MUTANT GLIOMAS
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errZiv, Michal Nisnboym; Sadeghipour, Negar; Xiu, Joanne; Nicolaides, Theodore; Ahluwalia, Manmeet; Glantz, Michael; Aulakh, Sonikpreet; Peters, Katherine B.
errShare
errSave
Volumetric tumor growth rate (TGR) modeling predicts clinical outcomes in patients with Grade 2, isocitrate dehydrogenase 1/2 mutant (mIDH1/2) glioma receiving vorasidenib or placebo in the Phase 3 INDIGO trial
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errEllingson, Benjamin M.; Mellinghoff, Ingo; Van Den Bent, Martin J.; Blumenthal, Deborah T.; Touat, Mehdi; Peters, Katherine B.; Clarke, Jennifer L.; Mendez, Joe; Yust-Katz, Shlomit; Welsh, Liam; Mason, Warren P.; Ducray, Francois; Umemura, Yoshie; Nabors, Burt; Holdhoff, Matthias; Hottinger, Andreas F.; Arakawa, Yoshiki; Sepulveda, Juan M.; Wick, Wolfgang; Soffietti, Riccardo; Perry, James; Giglio, Pierre; De La Fuente, Macarena, I; Maher, Elizabeth; Zhao, Dan; Pandya, Shuchi S.; Steelman, Lori; Hassan, Islam; Wen, Patrick Y.; Cloughesy, Timothy F.
errShare
errSave
PHASE 2, MULTICENTER, RANDOMIZED CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SAFUSIDENIB IN PATIENTS WITH HIGH-GRADE ISOCITRATE DEHYDROGENASE 1 (IDH1)-MUTANT GLIOMA
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
PREAI
errReardon, David; Umemura, Yoshie; Peters, Katherine; Mao, Ying; Cen, Yuling; Wei, Jianxin; Thomas, Piia; Iwamoto, Fabio
errShare
errSave
TARGETING FGFR ALTERATIONS IN GLIOMAS: A SINGLE-INSTITUTION CASE SERIES
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errShoaf, Madison L.; Patel, Mallika P.; Ashley, David M.; Batich, Kristen; Friedman, Henry S.; Johnson, Margaret O.; Khasraw, Mustafa; Low, Justin T.; Peters, Katherine B.; Desjardins, Annick
errShare
errSave
An assessment of the Tumor Monorail Device (TMD) for repeated sampling as part of a trial evaluating the combination of D2C7-IT and an Fc-engineered anti-CD40 monoclonal antibody (2141-V11) administered intratumorally via convection-enhanced delivery (CED) and cervical perilymphatic injections (CPLIs) of 2141-V11 in recurrent glioblastoma (rGBM) patients
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errDesjardins, Annick; Chandramohan, Vidya; Mokarram, Nassir; Meehan, Sean; Sharma, Shaili; Herndon Ii, James E.; Shoaf, Madison; Peters, Katherine B.; Johnson, Margaret O.; Batich, Kristen; Low, Justin; Khasraw, Mustafa; Friedman, Allan H.; Friedman, Henry S.; Ashley, David M.; Grant, Gerald; Osorio, Juan; Ravetch, Jeffrey; Bellamkonda, Ravi; Bigner, Darell D.
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
M
Michael Weller
H-index: 175 · Papers: 2.8K
D
Darell D. Bigner
H-index: 147 · Papers: 1.1K
P
Patrick Y. Wen
H-index: 145 · Papers: 1.9K
W
Wolfgang Wick
H-index: 142 · Papers: 1.6K
K
Kenneth Aldape
H-index: 141 · Papers: 1.1K
View more